Gene Therapy Working Group

The SECB's Gene Therapy Working Group is responsible for evaluating experimental gene therapy.

Members of the Gene Therapy Working Group


  • Pascal Meylan, Prof. MD, University Hospital Center (CHUV), Lausanne

Members (external experts)

  • Carlo V. Catapano, MD, PhD, Oncology Institute of Southern Switzerland, Bellinzona
  • Angela Ciuffi, Prof. PhD, Lausanne University Hospital Center and University of Lausanne (CHUV-UNIL)
  • Hussein Naim, PhD, Life Sciences and Vaccines Consultant, Bern
  • Janine Reichenbach, Prof. MD, Kinderspital Universität Zürich
  • Pedro Romero, Prof. MD, Ludwig Institute for Cancer Research, Lausanne
  • Sandro Rusconi, Prof. PhD, Repubblica e Cantone Ticino, Divisione della Cultura e degli Studi Universitari, Bellinzona

Executive Office

  • Elisabetta Peduzzi, PhD, Executive Manager SECB, Bern

To the top

Last edition: 04.01.2021